Australia’s fastest-growing women’s cancer is largely preventable — yet most women have never heard of it MEDIA RELEASE 1 June 2026 Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains National data confirms uterine cancer incidence has [...]
Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains MEDIA RELEASE 13 May 2026 Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains The Australia New Zealand Gynaecological Oncology Group [...]
AMPLIA THERAPEUTICS AND AUSTRALIA NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP (ANZGOG) ANNOUNCE OVARIAN CANCER STUDY Media Release - 8 May 2026 Highlights Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in [...]
Each year, ANZGOG’s Annual Scientific Meeting brings together leading experts from across Australia, New Zealand and the international community to share knowledge, exchange ideas and strengthen collaboration. At ASM 2026, we were pleased to welcome three keynote speakers [...]
ANZGOG members were recognised for their outstanding contributions to improving outcomes for everyone with a lived experience of gynaecological cancer during the ANZGOG 2026 Annual Scientific Meeting conference dinner. The ANZGOG Recognition Awards are a chance to recognise [...]
Celebrating the people behind #ANZGOG2026ASM As another extraordinary ANZGOG Annual Scientific Meeting (ASM) comes to a close, we take a moment to reflect not only on the science, collaboration and shared purpose that define this event, but [...]
On the Edge of Change: ANZGOG 2026 ASM showcases the power of innovation, collaboration and impact The ANZGOG 2026 Annual Scientific Meeting (ASM) marked a significant milestone for our community, bringing together a record 387 delegates, our largest [...]
STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer Media Release - 24 February 2026 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) [...]
More than half of women diagnosed will die — the ovarian cancer reality Australia can’t ignore Ovarian cancer remains the most lethal cancer affecting women, yet it continues to receive a fraction of the attention and investment [...]
ANZGOG welcomes three new Board Directors, expanding expertise and strengthening governance to advance gynaecological cancer research The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to announce the appointment of three new Board Directors: Beth Slatyer, Catherine Whitby [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
